Proteomic analysis of the pathophysiological process involved in the antisnake venom effect of Mucuna pruriens extract

Proteomics
R GuerrantiR Pagani

Abstract

Previously, we reported the antisnake venom properties of a Mucuna pruriens seed extract (MPE) and tested its in vivo efficacy against Echis carinatus venom (EV) in short- (1 injection) and long-term (three weekly injections) treatments. The aim of the present study was to investigate plasma proteome changes associated with MPE treatments and identify proteins responsible for survival of envenomated mice (CHALLENGED mice). Six treatment groups were studied. Three control groups: one saline, one short-term and one long-term MPE treatment. One group received EV alone. Two test groups received EV with either a short-term or long-term MPE treatment (CHALLENGED mice). The plasma from each group was analysed by 2-DE/MALDI-TOF MS. The most significant changes with treatment were: albumin, haptoglobin, fibrinogen, serum amyloid A and serum amyloid P. Most of these changes were explained by EV effects on coagulation, inflammation and haemolysis. However, MPE treatments prevented the EV-induced elevation in HPT. Consequently, HPT levels were similar to controls in the plasma of CHALLENGED mice. The plasma of CHALLENGED mice showed substantial proteomic modifications. This suggests the mechanism of MPE protection involves the activation o...Continue Reading

References

Oct 1, 1992·Toxicon : Official Journal of the International Society on Toxinology·W Martz
Apr 1, 1991·The American Journal of Tropical Medicine and Hygiene·J R WeisG M Rodgers
Oct 1, 1994·Journal of Ethnopharmacology·P J Houghton, K P Skari
May 1, 1993·Journal of Ethnopharmacology·P J Houghton, I M Osibogun
Sep 18, 1997·Immunology Today·H TilgJ W Mier
May 1, 1999·Experimental Cell Research·H VorumB Honoré
Dec 23, 1999·Current Opinion in Hematology·S Urieli-ShovalY Matzner
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·E A Dennis
Apr 25, 2000·Toxicon : Official Journal of the International Society on Toxinology·M LifshitzS Sofer
Apr 12, 2001·Journal of Ethnopharmacology·R GuerrantiE Marinello
Feb 28, 2002·The Journal of Biological Chemistry·Roberto GuerrantiEnrico Marinello
May 22, 2002·Journal of Ethnopharmacology·A K SinghJ S Singh
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Apr 5, 2003·Toxicon : Official Journal of the International Society on Toxinology·R D G TheakstonE Griffiths
Aug 2, 2003·Toxicon : Official Journal of the International Society on Toxinology·G D LaingR D G Theakston
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William C S ChoCadmon K P Lim
Apr 22, 2004·Veterinary Research·Henrik Hagbard PetersenPeter Mikael Helweg Heegaard
Nov 19, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·R KatzenschlagerA J Lees
Oct 27, 2005·Current Medicinal Chemistry·Andreimar M SoaresPaulo S Pereira
Oct 26, 2006·Annals of Surgical Oncology·De-Chuan ChanJenn-Han Chen

❮ Previous
Next ❯

Citations

Jan 19, 2013·Plant Foods for Human Nutrition·Lorenza BellaniSimonetta Muccifora
Sep 16, 2010·Age·Juan Ding, John J Kopchick
May 12, 2009·Journal of Ethnopharmacology·Nget Hong TanJohn C Aguiyi
Sep 27, 2008·Toxicon : Official Journal of the International Society on Toxinology·Shuqing LiuQingyin Zheng
Mar 27, 2012·Phytotherapy Research : PTR·Nnadozie Stanley Hope-OnyekwereRoberto Guerranti
Mar 15, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Andrea ScirèRoberto Guerranti
Aug 21, 2019·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Abraham Yirgu, Jean-Philippe Chippaux

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.